Trodelvy showed fewer severe side effects, such as neutropenia and diarrhea, compared to chemotherapy in untreated TNBC ...

Please provide your email address to receive an email when new articles are posted on . In certain settings. Whether a patient has cancer or not, we are trained to reach into our toolbox for whatever ...

Allogeneic hematopoietic SCT (allo-HSCT) is a potentially curative treatment for hematological malignancies and blood diseases. 1 As for the HSC grafts, historically autologous and allogeneic ...

Despite showing preclinical promise, granulocyte colony-stimulating factor (G-CSF) fails to improve clinical outcomes in acute ischemic stroke patients, according to results published online August 20 ...

Clinical studies examining the use of G-CSF in critically ill patients without hematologic disease and immunosuppression included mostly patients with severe sepsis and septic shock. These studies ...

Lee Schwartzberg, MD, FACP: While colony-stimulating factors like G-CSF [granulocyte colony-stimulating factor] have revolutionized the approach to chemotherapy-induced neutropenia [CIN] and febrile ...

Despite a meaningful survival, neutropenia is independently associated with poor outcomes among critically ill patients with cancer, according to a new study. However, neutropenia was no longer ...

Medically reviewed by Doru Paul, MD Key Takeaways Leukopenia refers to an abnormally low number of white blood cells, ...

The persuasive Global G-CSF/PEG-G-CSF Market report suggests that the key market players are making moves like product launches, joint ventures, developments, mergers and acquisitions which has ...